18m
ADMA Biologics Inc (ADMA) reports a 65% revenue surge and outlines future growth strategies amid regulatory and operational ...
Mersana Therapeutics Inc (MRSN) reports promising clinical progress and improved financial metrics, positioning itself ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback